Lv21
178 积分 2024-09-09 加入
IL‐17F facilitates prostate cancer cell malignant phenotypes via activation of the PI3K/AKT signalling pathway
20天前
已完结
Chronic NaAsO2 exposure promotes migration and invasion of prostate cancer cells by Akt/GSK-3β/β-catenin/TCF4 axis-mediated epithelial-mesenchymal transition
20天前
已完结
PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation
20天前
已完结
CRH upregulates supervillin through ERK and AKT pathways to promote bladder cancer cell migration
1个月前
已完结
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
1个月前
已完结
Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway
1个月前
已完结
PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance
1个月前
已完结
RAB3D, upregulated by aryl hydrocarbon receptor (AhR), promotes the progression of prostate cancer by activating the PI3K/AKT signaling pathway
1个月前
已完结
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
1个月前
已完结
The development of modulators for lysophosphatidic acid receptors: A comprehensive review
1个月前
已完结
皖公网安备34019202002308
